Summary: Ketamine, an anesthetic drug that blocks the brain’s N-methyl-D-aspartate (NMDA) receptor, has a rapid antidepressant effect at sub-anesthetic doses. A recent study found how it works in chronic pain. A protein called Tiam1 drives pain-induced depressive-like behaviors. Ketamine blocks Tiam1-mediated maladaptive synaptic plasticity (harmful rewiring) in ACC neurons.
Chronic pain and depression feed each other. Chronic pain can cause depression, and depression can make chronic pain worse. Researchers have found that ketamine therapy, an anesthetic drug that blocks the brain’s NMDA receptor, can have a rapid antidepressant effect. The key is giving it at sub-anesthetic doses (below the dose that puts you under). A recent study also found that a protein called Tiam1 is critical here. It is key to how chronic pain leads to depressive-like behaviors. Ketamine therapy may be a promising treatment because it blocks this Tiam1-driven rewiring in ACC neurons.
Chronic pain is a big and common problem in the United States. It hits millions of people. The National Institutes of Health (NIH) defines chronic pain as pain lasting 3-6 months or longer. Many conditions can cause it, including arthritis, fibromyalgia, back pain, neuropathy, and others. Chronic pain can significantly hurt a person’s quality of life. It disrupts sleep, work, and relationships. Chronic pain is also associated with a greater risk of depression. The link between chronic pain and depression runs both ways. Chronic pain can cause depression, and depression can make chronic pain worse. Studies have shown that people with chronic pain are three times more likely to develop depression than those without it. This is most true for people with severe, disabling pain.
Ketamine therapy is emerging as a new treatment for chronic pain and the depression that comes with it. Ketamine is an anesthetic drug used in hospitals for many years. In recent years, researchers found that ketamine can have a rapid antidepressant effect at sub-anesthetic doses. Ketamine works by blocking the NMDA receptor in the brain. This receptor is thought to play a role in depression.
Studies have shown that ketamine therapy can reduce pain and improve mood in people with chronic pain and depression. For example, one study found that a single intravenous infusion of ketamine reduced pain in people with chronic pain for up to six weeks. Another study found that ketamine therapy reduced depression symptoms in people with treatment-resistant depression (depression that has not responded to other drugs).
Ketamine therapy is a promising treatment for chronic pain and the depression that comes with it. More research is needed to pin down how safe and effective ketamine therapy is in this group. Ketamine therapy should only be given by a trained medical professional in a controlled setting. That is because of the potential for abuse and side effects.
There is strong evidence that ketamine is excellent for managing chronic pain and depression. Yet how it works is still poorly understood. Researchers think it works by acting on certain parts of the brain. It also appears to promote brain rewiring, since its effect lasts so long. Even a single ketamine treatment may change how pain feels for a long time. It may also give quick and lasting relief to people with depression.
The new study identifies the mechanism behind ketamine’s antidepressant action in chronic pain patients
The new study explains how chronic pain often leads to depression and a worse outlook. The researchers looked at a protein called Tiam1 in the brain’s anterior cingulate cortex (ACC). This is the brain area which is overactive in people with chronic pain and depression.
Tiam1 is a protein that helps build dendrites, spines, and synapses (the branches and connections between nerve cells) as the brain develops. The researchers found that Tiam1 also helps control synaptic plasticity in ACC neurons. Synaptic plasticity is how links between nerve cells change. It is key for learning and memory.
In people with chronic pain, Tiam1 appears to drive maladaptive synaptic plasticity in ACC neurons. That leads to overactivity and depressive-like behaviors. But the researchers found that low-dose ketamine, an NMDA receptor antagonist (blocker), can block this Tiam1-mediated maladaptive synaptic plasticity in mouse models of chronic pain. It also produced lasting antidepressant-like effects in those mice.
In short, the study suggests that Tiam1 is a critical factor in how chronic pain leads to depressive-like behaviors. Ketamine therapy may be a promising treatment because it blocks this Tiam1-driven rewiring in ACC neurons.
Frequently asked questions
How does ketamine work for depression?
Ketamine blocks the NMDA receptor in the brain. This receptor is thought to play a role in depression. Given at sub-anesthetic doses, well below what is used for surgery, ketamine has a rapid antidepressant effect. It also appears to promote brain rewiring. That is why the benefit can outlast the drug itself.
Why does chronic pain cause depression?
The link runs both ways. Chronic pain can cause depression, and depression can make chronic pain worse. People with chronic pain are three times more likely to develop depression, especially when the pain is severe and disabling. In the brain, the anterior cingulate cortex (ACC) becomes overactive in people with chronic pain and depression.
What is Tiam1, and how does ketamine affect it?
Tiam1 is a protein that helps build dendrites, spines and synapses in the brain. It also controls synaptic plasticity in ACC neurons. In chronic pain, Tiam1 drives harmful rewiring of those neurons. That leads to overactivity and depressive-like behaviors. In mouse models of chronic pain, low-dose ketamine blocked that Tiam1-driven rewiring. It produced lasting antidepressant-like effects.
How long does ketamine pain relief last?
In one study, a single intravenous ketamine infusion reduced pain in people with chronic pain for up to six weeks. Ketamine appears to rewire the brain. So even a single treatment may change how pain is felt for a long time. It may also give quick, lasting relief to people with depression.
Who should give ketamine therapy?
Ketamine therapy should only be given by a trained medical professional in a controlled setting. Ketamine is an anesthetic used in hospitals for many years. It carries a potential for abuse and side effects. Supervision lets the team manage the dose and watch for side effects during treatment.
Dr. Gurpreet Singh Padda, MD, MBA, MHP
